001     157141
005     20241202132639.0
024 7 _ |a 10.1016/j.ccell.2020.06.004
|2 doi
024 7 _ |a pmid:32663469
|2 pmid
024 7 _ |a 1535-6108
|2 ISSN
024 7 _ |a 1878-3686
|2 ISSN
024 7 _ |a altmetric:85711431
|2 altmetric
037 _ _ |a DKFZ-2020-01427
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Gojo, Johannes
|b 0
245 _ _ |a Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma.
260 _ _ |a New York, NY
|c 2020
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1682426150_10672
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #LA:B062#
520 _ _ |a Ependymoma is a heterogeneous entity of central nervous system tumors with well-established molecular groups. Here, we apply single-cell RNA sequencing to analyze ependymomas across molecular groups and anatomic locations to investigate their intratumoral heterogeneity and developmental origins. Ependymomas are composed of a cellular hierarchy initiating from undifferentiated populations, which undergo impaired differentiation toward three lineages of neuronal-glial fate specification. While prognostically favorable groups of ependymoma predominantly harbor differentiated cells, aggressive groups are enriched for undifferentiated cell populations. The delineated transcriptomic signatures correlate with patient survival and define molecular dependencies for targeted treatment approaches. Taken together, our analyses reveal a developmental hierarchy underlying ependymomas relevant to biological and clinical behavior.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Englinger, Bernhard
|b 1
700 1 _ |a Jiang, Li
|b 2
700 1 _ |a Hübner, Jens M
|0 P:(DE-He78)a8c698e0904394407c5261932915daa5
|b 3
700 1 _ |a Shaw, McKenzie L
|b 4
700 1 _ |a Hack, Olivia A
|b 5
700 1 _ |a Madlener, Sibylle
|b 6
700 1 _ |a Kirchhofer, Dominik
|b 7
700 1 _ |a Liu, Ilon
|b 8
700 1 _ |a Pyrdol, Jason
|b 9
700 1 _ |a Hovestadt, Volker
|b 10
700 1 _ |a Mazzola, Emanuele
|b 11
700 1 _ |a Mathewson, Nathan D
|b 12
700 1 _ |a Trissal, Maria
|b 13
700 1 _ |a Lötsch, Daniela
|b 14
700 1 _ |a Dorfer, Christian
|b 15
700 1 _ |a Haberler, Christine
|b 16
700 1 _ |a Halfmann, Angela
|b 17
700 1 _ |a Mayr, Lisa
|b 18
700 1 _ |a Peyrl, Andreas
|b 19
700 1 _ |a Geyeregger, Rene
|b 20
700 1 _ |a Schwalm, Benjamin
|0 P:(DE-He78)9ce969bf1ac7913b3f2b1cf4dd7f823e
|b 21
700 1 _ |a Mauermann, Monica
|b 22
700 1 _ |a Pajtler, Kristian W
|0 P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d
|b 23
700 1 _ |a Milde, Till
|0 P:(DE-He78)0be2f86573954f87e97f8a4dbb05cb0f
|b 24
700 1 _ |a Shore, Marni E
|b 25
700 1 _ |a Geduldig, Jack E
|b 26
700 1 _ |a Pelton, Kristine
|b 27
700 1 _ |a Czech, Thomas
|b 28
700 1 _ |a Ashenberg, Orr
|b 29
700 1 _ |a Wucherpfennig, Kai W
|b 30
700 1 _ |a Rozenblatt-Rosen, Orit
|b 31
700 1 _ |a Alexandrescu, Sanda
|b 32
700 1 _ |a Ligon, Keith L
|b 33
700 1 _ |a Pfister, Stefan M
|0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
|b 34
700 1 _ |a Regev, Aviv
|b 35
700 1 _ |a Slavc, Irene
|b 36
700 1 _ |a Berger, Walter
|b 37
700 1 _ |a Suvà, Mario L
|b 38
700 1 _ |a Kool, Marcel
|0 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
|b 39
|e Last author
700 1 _ |a Filbin, Mariella G
|b 40
773 _ _ |a 10.1016/j.ccell.2020.06.004
|g Vol. 38, no. 1, p. 44 - 59.e9
|0 PERI:(DE-600)2074034-7
|n 1
|p 44 - 59.e9
|t Cancer cell
|v 38
|y 2020
|x 1535-6108
856 4 _ |u https://inrepo02.dkfz.de/record/157141/files/Gojo%20et%20al%20Cancer%20Cell_revised%20version.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/157141/files/Gojo%20et%20al%20Cancer%20Cell_revised%20version.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:inrepo02.dkfz.de:157141
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)a8c698e0904394407c5261932915daa5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)9ce969bf1ac7913b3f2b1cf4dd7f823e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 23
|6 P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 24
|6 P:(DE-He78)0be2f86573954f87e97f8a4dbb05cb0f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 34
|6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 39
|6 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Functional and structural genomics
|x 0
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-01-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
|d 2020-01-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-01-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2020-01-11
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
|d 2020-01-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-01-11
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
|d 2020-01-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-01-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2020-01-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2020-01-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2020-01-11
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER CELL : 2018
|d 2020-01-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-01-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2020-01-11
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2020-01-11
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b CANCER CELL : 2018
|d 2020-01-11
920 2 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 0
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 0
920 1 _ |0 I:(DE-He78)B310-20160331
|k B310
|l KKE Pädiatrische Onkologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)B310-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21